SCHOLAR ROCK HOLDING CORP (SRRK) Stock News

USA - NASDAQ:SRRK - US80706P1030 - Common Stock

32.34 USD

-1.33 (-3.95%)

Last: 9/16/2025, 4:44:31 PM

32.34 USD

0 (0%)

After Hours: 9/16/2025, 4:44:31 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

SRRK Latest News, Press Relases and Analysis

All

Press Releases

a day ago - By: The Motley Fool

Why Scholar Rock Stock Bounced Higher on Monday

4 days ago - By: Scholar Rock

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

8 days ago - By: Benzinga

How Do Investors Really Feel About Scholar Rock Holding?

15 days ago - By: Benzinga

Here's How Much $1000 Invested In Scholar Rock Holding 5 Years Ago Would Be Worth Today

a month ago - By: Yahoo Finance

Scholar Rock (SRRK) Jumps 14% on Bargain-Hunting, Price Down 20.4% YTD

a month ago - By: The Motley Fool

Scholar Rock (SRRK) Q2 Loss Widens 63%

a month ago - By: Scholar Rock

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

a month ago - By: Zacks Investment Research - Mentions: REGN LLY VERU

Veru Announces Novel Modified-Release Oral Formulation for Enobosarm

a month ago - By: Scholar Rock

Pivotal SAPPHIRE Trial Data Published in The Lancet Neurology: Apitegromab Demonstrated Significant Motor Function Gains for Children and Adults with SMA on SMN-Targeted Treatment

a month ago - By: Yahoo Finance

Why Scholar Rock Stock Wilted on Wednesday

a month ago - By: Scholar Rock

Scholar Rock Reports Second Quarter 2025 Financial Results and Highlights Business Progress

2 months ago - By: Scholar Rock

Scholar Rock to Host Conference Call to Discuss Second Quarter 2025 Financial Results and Provide Business Update on August 6, 2025

2 months ago - By: Scholar Rock

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

3 months ago - By: Scholar Rock

Scholar Rock to Present Comprehensive Update at 2025 Annual Cure SMA Research and Clinical Care Meeting, Including Positive Results from Pivotal Phase 3 SAPPHIRE Trial

3 months ago - By: Yahoo Finance

Scholar Rock (SRRK) Jumps 16.6% After Successful Weight Loss Drug Trial

3 months ago - By: Stocktwits - Mentions: REGN VTI LLY COIN

Scholar Rock Stock Soars After Investigational Drug Helps Preserve Lean Mass: Retail Flags Lack Of Incremental Weight Loss

3 months ago - By: Scholar Rock

Scholar Rock Reports Positive Phase 2 EMBRAZE Trial Results Demonstrating Statistically Significant Preservation of Lean Mass with Apitegromab During Tirzepatide-Induced Weight Loss

3 months ago - By: Scholar Rock

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

3 months ago - By: Stocktwits - Mentions: AKRO VTI PFE LLY ...

Jefferies Names Akero Therapeutics, Scholar Rock As Biotech Companies With Takeover Potential, But Retail Isn’t Pleased

3 months ago - By: Scholar Rock

Scholar Rock to Participate in the 46th Annual Goldman Sachs Global Healthcare Conference

4 months ago - By: Scholar Rock

Scholar Rock Appoints Rebecca McLeod Chief Brand Officer and U.S. General Manager

4 months ago - By: Scholar Rock

Scholar Rock to Present at the Jefferies Global Healthcare Conference

4 months ago - By: Scholar Rock

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

4 months ago - By: Scholar Rock

Scholar Rock Reports First Quarter 2025 Financial Results and Highlights Business Progress

4 months ago - By: Scholar Rock

Scholar Rock to Host Conference Call to Discuss First Quarter 2025 Financial Results and Provide Business Update on May 14, 2025

4 months ago - By: Scholar Rock

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)